Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
digital therapeutics
MedTech
FDA clears Lumosity brain training games for adult ADHD
Dubbed LumosityRx, the agency's 510(k) covers the smartphone app's use in improving attention among people between the ages of 22 and 55.
Joseph Keenan
Dec 11, 2025 10:00am
Boehringer, Click DTx hits phase 3 goal in schizophrenia
Oct 14, 2025 12:08pm
FDA clears prescription migraine app from Click Therapeutics
Apr 17, 2025 11:35am
ADHD game developer Akili Interactive sold for $34M
May 30, 2024 11:23am
Click picks up Better's app assets in diabetes, obesity
May 22, 2024 10:00am
FDA clears Otsuka, Click's prescription app for depression
Apr 3, 2024 1:53pm
